These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31787111)

  • 1. Priming primary care providers to engage in evidence-based discussions about cannabis with patients.
    Kansagara D; Becker WC; Ayers C; Tetrault JM
    Addict Sci Clin Pract; 2019 Dec; 14(1):42. PubMed ID: 31787111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Drug Culture: Medical and Recreational Marijuana.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana Legalization: Impact on Physicians and Public Health.
    Wilkinson ST; Yarnell S; Radhakrishnan R; Ball SA; D'Souza DC
    Annu Rev Med; 2016; 67():453-66. PubMed ID: 26515984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis Essentials: Tools for Clinical Practice.
    Sazegar P
    Am Fam Physician; 2021 Dec; 104(6):598-608. PubMed ID: 34913644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use.
    Budney AJ; Sofis MJ; Borodovsky JT
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):73-86. PubMed ID: 30604051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: An analysis of states by year, 2008-2017.
    Mennis J; Stahler GJ; McKeon TP
    Addict Behav; 2021 Dec; 123():107049. PubMed ID: 34303941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and psychiatric illness in the context of medical marijuana legalization: A clinical perspective.
    Yuan M; Kanellopoulos T; Kotbi N
    Gen Hosp Psychiatry; 2019; 61():82-83. PubMed ID: 31488324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Cannabis.
    Ebbert JO; Scharf EL; Hurt RT
    Mayo Clin Proc; 2018 Dec; 93(12):1842-1847. PubMed ID: 30522595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis legalization: progress in harm reduction approaches for substance use and misuse.
    Adinoff B; Cooper ZD
    Am J Drug Alcohol Abuse; 2019; 45(6):707-712. PubMed ID: 31755837
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabis for Chronic Pain: Challenges and Considerations.
    Romero-Sandoval EA; Fincham JE; Kolano AL; Sharpe BN; Alvarado-Vázquez PA
    Pharmacotherapy; 2018 Jun; 38(6):651-662. PubMed ID: 29637590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Are Adolescent Cannabis Use Disorder Treatment Admissions Declining in the US? The Mediated Pathway of State Treatment Admissions Rates before and after Recreational Cannabis Legalization.
    Mennis J; Stahler GJ; Coffman DL
    Subst Use Misuse; 2024; 59(6):962-970. PubMed ID: 38297820
    [No Abstract]   [Full Text] [Related]  

  • 13. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.
    Hefner K; Sofuoglu M; Rosenheck R
    Am J Addict; 2015 Sep; 24(6):538-45. PubMed ID: 26246069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders.
    N S Gendy M; Taisir R; Sousa S; Costello J; Rush B; Busse JW; Mackillop J
    Addict Behav; 2023 Jul; 142():107667. PubMed ID: 36893511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana for Glaucoma: A Recipe for Disaster or Treatment?
    Sun X; Xu CS; Chadha N; Chen A; Liu J
    Yale J Biol Med; 2015 Sep; 88(3):265-9. PubMed ID: 26339209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical consequences of marijuana use: a review of current literature.
    Gordon AJ; Conley JW; Gordon JM
    Curr Psychiatry Rep; 2013 Dec; 15(12):419. PubMed ID: 24234874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US Epidemiology of Cannabis Use and Associated Problems.
    Hasin DS
    Neuropsychopharmacology; 2018 Jan; 43(1):195-212. PubMed ID: 28853439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and adolescents: Exploring the substance misuse treatment provider experience in a climate of legalization.
    Sobesky M; Gorgens K
    Int J Drug Policy; 2016 Jul; 33():66-74. PubMed ID: 26992485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence.
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Sleep Med; 2010 May; 11(5):499-500. PubMed ID: 20138005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.